Association between dispensing of low-value oral albuterol and removal from Medicaid preferred drug lists
Abstract Background Oral albuterol has worse efficacy and side effects compared with inhaled albuterol, and thus its use has been discouraged for decades. Drug inclusion or exclusion on formularies have been associated with reductions in low-value care. This study examines dispensing of oral albuter...
Saved in:
Main Authors: | Anna Volerman (Author), Alison Pelczar (Author), Rena Conti (Author), Christina Ciaccio (Author), Kao-Ping Chua (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prescription Drug Recalls on Florida's Medicaid Preferred Drug List
by: Josephine M. Kershaw, et al.
Published: (2005) -
Acute Effects of Albuterol on Ventilatory Capacity in Children with Asthma
by: Michael W. H. Wong, et al.
Published: (2024) -
Albuterol Use in Children Hospitalized with Human Metapneumovirus Respiratory Infection
by: Lindsey K. Rasmussen, et al.
Published: (2016) -
Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis
by: Talmon Gil, et al.
Published: (2007) -
Protective Effects of Albuterol, Epinephrine and Cromolyn Against Ovalbumine-Induced Immunotoxicity in the Rat Lungs
by: Raham Armand, et al.
Published: (2020)